drugset / Trial / NCT06586606

A Study to Evaluate the Effects of Itraconazole on MK-1708 in Healthy Participants (MK-1708-003)

NCT06586606 ↗

Phase 1 Completed 12 enrolled Merck Sharp & Dohme LLC
Non-randomizedSequentialOpen-labelTreatment

Summary

The goal of the study is to see what happens to levels of MK-1708 a person's body over time. Researchers will compare what happens to MK-1708 in the body when it is given with or without a medicine called itraconazole.

Timeline

Start
2024-10-03
Primary completion
2024-12-10
Completion
2024-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — Oral
Subject MK-1708 Unknown — Oral

Indications